As of close of business last night, Applied Therapeutics Inc’s stock clocked out at $5.16, down -3.37% from its previous closing price of $5.34. On the day, 664820 shares were traded.
Ratios:
To gain a deeper understanding of APLT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on March 26, 2024, initiated with a Outperform rating and assigned the stock a target price of $12.
On February 22, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $12.
Barclays Downgraded its Overweight to Equal Weight on January 04, 2022, whereas the target price for the stock was revised from $44 to $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 14 ’24 when Shendelman Shoshana sold 318,573 shares for $5.39 per share. The transaction valued at 1,717,108 led to the insider holds 3,817,814 shares of the business.
Perfetti Riccardo sold 110,804 shares of APLT for $597,234 on Mar 14 ’24. The Chief Medical Officer now owns 1,031,537 shares after completing the transaction at $5.39 per share. On Mar 14 ’24, another insider, Hansard Adam, who serves as the Chief Commercial Officer of the company, sold 48,871 shares for $5.39 each. As a result, the insider received 263,415 and left with 732,919 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 51.26.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $9.39, while it has fallen to a 52-week low of $0.77.
Shares Statistics:
A total of 84.87M shares are outstanding, with a floating share count of 82.80M. Insiders hold about 21.80% of the company’s shares, while institutions hold 56.10% stake in the company.
